Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$407,747
+$17,546 QoQ
Shares Held
1,126
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#2,335
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST PACES ADVISORS INC. holds $9,117,824 across 12 Drug Manufacturers - General names. AMGN ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,426 | $2,909,817 | |
| 2 | JNJ |
Johnson & Johnson
|
9,783 | $2,484,588 | |
| 3 | ABBV |
AbbVie Inc.
|
8,090 | $2,035,767 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,717 | $863,134 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,126 | $407,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,222 | $280,727 | |
| 7 | PFE |
Pfizer Inc
|
2,704 | $65,112 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
648 | $37,337 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $407,747 | 1,126 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $390,201 | 1,109 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $362,986 | 1,109 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $298,567 | 1,058 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $294,008 | 1,053 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $328,062 | 1,053 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $314,331 | 1,206 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $543,246 | 1,686 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $577,720 | 1,849 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $528,266 | 1,858 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $523,908 | 1,819 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $345,356 | 1,285 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $335,694 | 1,512 | Shares | Sole | 2023-12-18 | |
| 2023-03-31 | $402,997 | 1,667 | Shares | Sole | 2023-12-18 | |
| 2022-12-31 | $448,851 | 1,709 | Shares | Sole | 2023-12-18 | |
| 2022-09-30 | $377,545 | 1,675 | Shares | Sole | 2023-12-19 | |
| 2022-06-30 | $422,368 | 1,736 | Shares | Sole | 2023-12-19 | |
| 2022-03-31 | $442,046 | 1,828 | Shares | Sole | 2023-12-19 | |
| 2021-12-31 | $405,170 | 1,801 | Shares | Sole | 2023-12-20 | |
| 2021-09-30 | $675,163 | 3,175 | Shares | Sole | 2023-12-20 | |
| 2021-06-30 | $703,462 | 2,886 | Shares | Sole | 2023-12-20 | |
| 2021-03-31 | $729,262 | 2,931 | Shares | Sole | 2023-12-20 | |
| 2020-12-31 | $660,790 | 2,874 | Shares | Sole | 2023-12-20 | |
| 2020-09-30 | $811,278 | 3,192 | Shares | Sole | 2023-12-20 | |
| 2020-06-30 | $759,233 | 3,219 | Shares | Sole | 2023-12-20 | |
| 2020-03-31 | $652,587 | 3,219 | Shares | Sole | 2023-12-21 | |
| No filing history on record for this holder in this stock. | ||||||